Computational study of glycopeptide antibiotics interactions with Staphylococcus aureus peptidoglycan.

dc.contributor.advisorShuford, Kevin L.
dc.creatorOlademehin, Olatunde P., 1985-
dc.creator.orcid0000-0002-5987-1172
dc.date.accessioned2021-10-08T13:48:30Z
dc.date.available2021-10-08T13:48:30Z
dc.date.created2021-08
dc.date.issued2021-08-04
dc.date.submittedAugust 2021
dc.date.updated2021-10-08T13:48:32Z
dc.description.abstractStaphylococcus aureus is generally known for its ability to acquire resistance to any antibiotic. Methicillin-resistant S. aureus is one of the leading etiological agents responsible for the hospital- and community-acquired infections. Due to the rise of multidrug resistant bacteria, there is a great need for continuous discovery and development of new antibiotics to overcome the inevitable emergence of antibiotic resistance in pathogens. Numerous classes of antibiotics, including glycopeptide antibiotics, target bacterial cell wall biosynthesis, where the cell wall plays an essential role in maintaining the structural integrity and morphology of bacteria. The major component of the cell wall is peptidoglycan (PG), a unique feature found in all bacteria. Inhibition of PG biosynthesis during cell growth results in bacterial cell lysis. This dissertation examines the glycopeptide antibiotics interactions with PG by molecular dynamics simulations to provide insight into modifying existing therapeutics or developing novel pharmacological therapeutics. Steered molecular dynamics simulations and umbrella sampling were also applied, when necessary, to characterize the thermodynamic properties and the dynamics of select glycopeptide-PG complexes. Our simulations provide insights into the role of amino acid residues, which are not directly involved in the dipeptide binding of glycopeptides, in improving the binding of the glycopeptides to PG. We also reveal computational evidence of a secondary-binding site contributing to the enhancement in the binding of oritavancin to PG compared to other glycopeptide antibiotics lacking the additional binding interactions.
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://hdl.handle.net/2104/11619
dc.language.isoen
dc.rights.accessrightsWorldwide access
dc.subjectStaphylococcus aureus. Glycopeptide. Peptidoglycan. Oritavancin.
dc.titleComputational study of glycopeptide antibiotics interactions with Staphylococcus aureus peptidoglycan.
dc.typeThesis
dc.type.materialtext
thesis.degree.departmentBaylor University. Dept. of Chemistry & Biochemistry.
thesis.degree.grantorBaylor University
thesis.degree.levelDoctoral
thesis.degree.namePh.D.

Files

Original bundle

Now showing 1 - 4 of 4
Loading...
Thumbnail Image
Name:
OLADEMEHIN-DISSERTATION-2021.pdf
Size:
35.74 MB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
Olatunde_Olademehin_CopyrightAvailabilityForm.pdf
Size:
193.72 KB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
Olatunde_Olademehin_Chapter three manuscript - with permission.png
Size:
968.19 KB
Format:
Portable Network Graphics
No Thumbnail Available
Name:
Olatunde_Olademehin_Chapter four manuscript - with permission.png
Size:
1008.43 KB
Format:
Portable Network Graphics

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
LICENSE.txt
Size:
1.96 KB
Format:
Plain Text
Description: